Account
Inquiry
The GLP-1 Peptide Weight Loss Injection Pen represents the next generation of precision medication delivery devices for diabetes management and metabolic treatments. This disposable injector combines advanced engineering with user-friendly design to provide healthcare professionals and patients with reliable dosing accuracy.
Key features include multiple dosage settings (0-0.25mg-0.5mg-1mg) with 0.01mL minimum increments, suitable for various GLP-1 peptides including semaglutide, liraglutide, and tirzepatide. The device accommodates standard 3mL cartridges and offers customizable appearance options to meet different clinical and patient preferences.
With pressing force optimized below 8N (for 74/80 unit models) and clear dose indicators, this pen injector ensures comfortable administration while maintaining medication integrity. The product has completed comprehensive FTO (Freedom to Operate) reviews in major markets including China and the United States, with regulatory submissions for CE MDR and FDA 510(k) clearance currently in progress.
The injection pen's versatile design supports multiple therapeutic applications including diabetes care (insulin and GLP-1 receptor agonists), weight management protocols, and endocrine treatments. Its precision-engineered mechanism delivers consistent dosing accuracy across the entire dosage range, backed by extensive clinical validation data.
